Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbiota refers to the community of microorganisms—including bacteria, archaea, fungi, protists, and viruses—that exist within a specific environment or host, such as the human gut, skin, or respiratory tract[1][5]. In humans, the microbiota is essential for maintaining physiological homeostasis, particularly influencing nutrition, metabolism, immune modulation, colonization resistance against pathogens, vitamin production, and even communication along the gut-brain axis[1][5][9]. Dysbiosis, or disruption of the normal microbiota, is increasingly recognized as a contributor to a wide variety of diseases, including infections, inflammatory and autoimmune conditions, metabolic disorders, cardiovascular diseases, neurodegenerative diseases, and cancer[5][6][8]. While not a single molecular target, the modulation of microbiota composition—using probiotics, prebiotics, antibiotics, bacteriophages, or fecal microbiota transplantation—represents a novel and evolving area of therapeutic intervention, albeit with significant complexity and safety considerations[2][6][8].
Restoration or alteration of microbial community diversity/composition; Suppression of pathogenic species (subtractive therapy); Stimulation of beneficial commensals (additive therapy); Modulation of host immune response via microbial metabolites; Competitive exclusion/colonization resistance; Reestablishment of homeostasis in dysbiosis
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbiota.